Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: Q4QJ50
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006401 | RNA catabolic process | 5 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009056 | catabolic process | 2 | 2 |
GO:0009057 | macromolecule catabolic process | 4 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0019439 | aromatic compound catabolic process | 4 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034655 | nucleobase-containing compound catabolic process | 4 | 2 |
GO:0043137 | DNA replication, removal of RNA primer | 6 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044248 | cellular catabolic process | 3 | 2 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 2 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 2 |
GO:0044270 | cellular nitrogen compound catabolic process | 4 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0046700 | heterocycle catabolic process | 4 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5 | 2 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 6 | 2 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 7 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
GO:1901361 | organic cyclic compound catabolic process | 4 | 2 |
GO:1901575 | organic substance catabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000287 | magnesium ion binding | 5 | 12 |
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004518 | nuclease activity | 4 | 12 |
GO:0004519 | endonuclease activity | 5 | 12 |
GO:0004521 | RNA endonuclease activity | 5 | 12 |
GO:0004523 | RNA-DNA hybrid ribonuclease activity | 7 | 12 |
GO:0004540 | RNA nuclease activity | 4 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 12 |
GO:0016891 | RNA endonuclease activity, producing 5'-phosphomonoesters | 6 | 12 |
GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043169 | cation binding | 3 | 12 |
GO:0046872 | metal ion binding | 4 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 235 | 239 | PF00656 | 0.380 |
CLV_PCSK_SKI1_1 | 140 | 144 | PF00082 | 0.391 |
DEG_SPOP_SBC_1 | 19 | 23 | PF00917 | 0.679 |
DOC_CYCLIN_yCln2_LP_2 | 118 | 124 | PF00134 | 0.243 |
DOC_MAPK_gen_1 | 213 | 222 | PF00069 | 0.347 |
DOC_MAPK_MEF2A_6 | 120 | 127 | PF00069 | 0.280 |
DOC_PP4_FxxP_1 | 64 | 67 | PF00568 | 0.210 |
DOC_USP7_MATH_1 | 8 | 12 | PF00917 | 0.601 |
DOC_WW_Pin1_4 | 23 | 28 | PF00397 | 0.580 |
DOC_WW_Pin1_4 | 6 | 11 | PF00397 | 0.579 |
LIG_14-3-3_CanoR_1 | 173 | 178 | PF00244 | 0.431 |
LIG_14-3-3_CanoR_1 | 62 | 67 | PF00244 | 0.286 |
LIG_14-3-3_CterR_2 | 246 | 250 | PF00244 | 0.450 |
LIG_APCC_ABBA_1 | 125 | 130 | PF00400 | 0.229 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.519 |
LIG_FHA_1 | 103 | 109 | PF00498 | 0.449 |
LIG_FHA_1 | 117 | 123 | PF00498 | 0.261 |
LIG_KLC1_Yacidic_2 | 31 | 36 | PF13176 | 0.303 |
LIG_LIR_Gen_1 | 172 | 179 | PF02991 | 0.491 |
LIG_LIR_Nem_3 | 111 | 116 | PF02991 | 0.217 |
LIG_LIR_Nem_3 | 162 | 167 | PF02991 | 0.238 |
LIG_LIR_Nem_3 | 172 | 177 | PF02991 | 0.301 |
LIG_SH2_CRK | 174 | 178 | PF00017 | 0.458 |
LIG_SH2_SRC | 34 | 37 | PF00017 | 0.229 |
LIG_SH2_STAP1 | 141 | 145 | PF00017 | 0.356 |
LIG_SH2_STAT3 | 178 | 181 | PF00017 | 0.477 |
LIG_SH2_STAT3 | 207 | 210 | PF00017 | 0.485 |
LIG_SH2_STAT5 | 128 | 131 | PF00017 | 0.300 |
LIG_SH2_STAT5 | 133 | 136 | PF00017 | 0.274 |
LIG_SH2_STAT5 | 207 | 210 | PF00017 | 0.687 |
LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.229 |
LIG_SUMO_SIM_anti_2 | 217 | 224 | PF11976 | 0.394 |
LIG_SUMO_SIM_anti_2 | 238 | 245 | PF11976 | 0.387 |
LIG_SUMO_SIM_par_1 | 114 | 119 | PF11976 | 0.142 |
LIG_TRAF2_2 | 157 | 162 | PF00917 | 0.280 |
MOD_CK1_1 | 6 | 12 | PF00069 | 0.593 |
MOD_CK2_1 | 150 | 156 | PF00069 | 0.352 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.632 |
MOD_GlcNHglycan | 109 | 113 | PF01048 | 0.280 |
MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.671 |
MOD_GSK3_1 | 17 | 24 | PF00069 | 0.658 |
MOD_GSK3_1 | 37 | 44 | PF00069 | 0.323 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.655 |
MOD_GSK3_1 | 68 | 75 | PF00069 | 0.362 |
MOD_LATS_1 | 224 | 230 | PF00433 | 0.439 |
MOD_N-GLC_1 | 41 | 46 | PF02516 | 0.307 |
MOD_N-GLC_1 | 62 | 67 | PF02516 | 0.319 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.619 |
MOD_NEK2_1 | 102 | 107 | PF00069 | 0.375 |
MOD_NEK2_1 | 150 | 155 | PF00069 | 0.282 |
MOD_NEK2_1 | 18 | 23 | PF00069 | 0.631 |
MOD_NEK2_1 | 236 | 241 | PF00069 | 0.341 |
MOD_NEK2_1 | 70 | 75 | PF00069 | 0.280 |
MOD_PIKK_1 | 42 | 48 | PF00454 | 0.180 |
MOD_PIKK_1 | 70 | 76 | PF00454 | 0.280 |
MOD_PKA_2 | 205 | 211 | PF00069 | 0.661 |
MOD_PKB_1 | 171 | 179 | PF00069 | 0.448 |
MOD_Plk_1 | 102 | 108 | PF00069 | 0.217 |
MOD_Plk_4 | 173 | 179 | PF00069 | 0.538 |
MOD_ProDKin_1 | 23 | 29 | PF00069 | 0.566 |
MOD_ProDKin_1 | 6 | 12 | PF00069 | 0.581 |
TRG_DiLeu_BaEn_1 | 103 | 108 | PF01217 | 0.217 |
TRG_DiLeu_BaEn_1 | 218 | 223 | PF01217 | 0.384 |
TRG_ENDOCYTIC_2 | 174 | 177 | PF00928 | 0.400 |
TRG_ENDOCYTIC_2 | 55 | 58 | PF00928 | 0.389 |
TRG_ER_diArg_1 | 168 | 171 | PF00400 | 0.270 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PC83 | Leptomonas seymouri | 61% | 72% |
A0A0S4IX23 | Bodo saltans | 36% | 82% |
A0A1X0NJL6 | Trypanosomatidae | 32% | 69% |
A0A3R7MD61 | Trypanosoma rangeli | 36% | 68% |
A0A3S7WPF2 | Leishmania donovani | 95% | 100% |
A4H4J5 | Leishmania braziliensis | 82% | 100% |
A4HSS0 | Leishmania infantum | 96% | 100% |
C9ZTC3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 83% |
E9AKQ7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
O60930 | Homo sapiens | 28% | 87% |
O70338 | Mus musculus | 27% | 88% |
Q5BK46 | Rattus norvegicus | 28% | 88% |
Q9UST8 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 29% | 95% |
V5BEV1 | Trypanosoma cruzi | 38% | 77% |